Carolina Liquid Chemistries Corp. Partners with Alltests Clinical Solutions, LLC to Distribute ACON Laboratories Flowflex™ COVID-19 Antigen Home Test

December 23, 2021

Greensboro, NC (December 22, 2021) – Veteran owned Carolina Liquid Chemistries Corp. (CLC) announced it has teamed up with New Jersey-based Alltests Clinical Solutions, LLC (Alltests), an authorized distributor, to distribute the Flowflex COVID-19 Antigen... Read more »

First Point-of-Care (POC) COVID-19 Antibody Test Now Available from Carolina Liquid Chemistries

October 5, 2020

FDA Emergency Use Authorization Reissued to Allow Fingerstick Blood Samples GREENSBORO, NC — (September 30, 2020) — The US Food and Drug Administration (FDA) announced that it has authorized the first antibody test intended for... Read more »

COVID-19 Test Kits Offered by Carolina Liquid Chemistries Granted FDA Emergency Use Authorization

July 28, 2020

Diagnostics Company Partners with Manufacturers to Bring Desperately Needed Molecular and Antibody Test Kits and Supplies to Market During the Pandemic GREENSBORO, NC — (July 28, 2020) — Carolina Liquid Chemistries, Corp. (CLC), an innovative... Read more »

Carolina Liquid Chemistries Launches Fentanyl Test

March 17, 2020

First Benchtop Clinical Chemistry Analyzer to offer a Moderately Complex Norfentanyl Test GREENSBORO, NC — (March 17, 2020) — Carolina Liquid Chemistries, Corp. (CLC), an innovative leader in clinical diagnostics and drug screening, has received... Read more »

CLC Now Offers Aldolase Assay for Use on Clinical Chemistry Analyzers

November 11, 2019

Reagent Aids in Diagnosis of Myocardial Infarction and Liver Disease GREENSBORO, NC — (November 11, 2019) — Carolina Liquid Chemistries, Corp. (CLC), an innovative leader in clinical diagnostics, announces a new addition to its menu... Read more »

APO A1, APO B and Rheumatoid Factor added to the CLC800 & CLC 1600 Test Menu

August 22, 2018

Carolina Liquid Chemistries Corp. (CLC) has recently added three moderately complex reagents to their already extensive menu of tests for the CLC800 and the CLC1600 clinical chemistry analyzers. The CLC800 is Carolina Liquid Chemistries’ cost-effective... Read more »

CLC Markets Test to Aid in Predicting Coronary Heart Disease

July 20, 2018

Carolina Liquid Chemistries Corp. (CLC) recently added the PLAC® test to their extensive menu of reagents for use on chemistry analyzers. The PLAC Test is an enzyme assay for the in vitro quantitative determination of... Read more »

Carolina Liquid Chemistries Successfully Launches High-Speed Benchtop Analyzer

June 26, 2018

Carolina Liquid Chemistries Corp., known for its clinical chemistry analyzers and reagents, announces the successful launch of Medica Corporation’s high-speed benchtop analyzer, the EasyRA®. The refreshed EasyRA clinical chemistry analyzer now offers double the throughput,... Read more »